Your browser doesn't support javascript.
loading
High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors.
Calo, Corinne A; Barrington, David A; Brown, Morgan; Gonzalez, Lynette; Baek, Jae; Huffman, Allison; Benedict, Jason; Backes, Floor; Chambers, Laura; Cohn, David; Copeland, Larry; Cosgrove, Casey; Nagel, Christa; O'Malley, David; Bixel, Kristin.
Afiliação
  • Calo CA; Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
  • Barrington DA; James Cancer Hospital, Division of Gynecologic Oncology, The Ohio State University, Columbus, OH, United States.
  • Brown M; Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
  • Gonzalez L; James Cancer Hospital, Division of Gynecologic Oncology, The Ohio State University, Columbus, OH, United States.
  • Baek J; Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
  • Huffman A; Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH, United States.
  • Benedict J; Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
  • Backes F; Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
  • Chambers L; Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
  • Cohn D; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States.
  • Copeland L; Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH, United States.
  • Cosgrove C; James Cancer Hospital, Division of Gynecologic Oncology, The Ohio State University, Columbus, OH, United States.
  • Nagel C; Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH, United States.
  • O'Malley D; James Cancer Hospital, Division of Gynecologic Oncology, The Ohio State University, Columbus, OH, United States.
  • Bixel K; Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH, United States.
Gynecol Oncol Rep ; 42: 101040, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35855965
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article